Immunoglobulin and granulocyte cytochemical reactions in L-asparaginase treated children with acute lymphoblastic leukemia
Zajaczkowski, L.; Pituch, A.; Legutko, L.
Medecine Interne 14(3): 191-195
1976
ISSN/ISBN: 0377-1202 PMID: 1071477 Document Number: 104769
The dose-dependent effect of L-asparaginase (Crasnitin, Bayer) on the serum IgG, IgA and IgM content was studied in 14 children with acute lymphoblastic leukemia. This effect was less evident in the intracellular metabolism of peripheral blood granulocytes (studied by the NBT test), in the myeloperoxidase and alkaline phosphatase activities and in the serum glycogen and lipid content.
Document emailed within 1 workday
Related Documents
Russo, G.; Schiliro, G. 1971: Treatment of acute lymphoblastic leukemia in children with L-asparaginase La Pediatria 79(1): 27-51Cetin, M.; Yetgin, S.; Kara, A.; Tuncer, A.M.; Günay, M.; Gümrük, F.; Gürgey, A. 1994: Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia Journal of Medicine 25(3-4): 219-229
Zajaczkowski, J.; Legutko, L.; Armata, J.; Halikowska-łacka, E. 1975: Results of repeated L-asparaginase treatment in acute lymphoblastic leukemia and lymphosarcoma in children Pediatria Polska 50(8): 985-990
Gu, Y.X.; Cui, Y.F.; Liu, X.T.; Bai, Y.; Tan, Z.X.; Zhang, D.F.; Lu, S.G. 1987: Cytochemical classification of acute lymphoblastic leukemia in children Chinese Medical Journal 100(8): 663-668
Pawińska, K.; Balwierz, W.; Sztefko, K.; Czogała, Młgorzata. 2006: Significance of L-asparaginase activity and biochemical parameters evaluation in children with acute lymphoblastic leukemia Przeglad Lekarski 63(1): 44-46
Rizzari, C.; Citterio, M.; Zucchetti, M.; Conter, V.; Chiesa, R.; Colombini, A.; Malguzzi, S.; Silvestri, D.; D'Incalci, M. 2006: A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia Haematologica 91(1): 24-31
Goudemand, M.; Delmas-Marsalet, Y.; Bauters, F. 1972: Allergic meningitis due to asparaginase sensitivity during acute lymphoblastic leukemia La Nouvelle Presse Medicale 1(4): 268
Massimo, L.; Cottafava, F.; Mori, P.G.; Fossati-Guglielmoni, A.; Dagna-Bricarelli, F. 1971: Preliminary results in the treatment of acute lymphoblastic leukemia in a child with L-asparaginase Minerva Pediatrica 23(26): 1130-1136
Esposito, L.; Benedetto, N.; Guerriero, A. 1980: Data on the immunological profile of children with acute lymphoblastic leukemia treated by immunotherapy La Pediatria 88(4): 521-531
Popa, A.V.; Maiakova, S.A.; Kurmashov, V.I. 1997: Therapeutic results in children with acute non-lymphoblastic leukemia treated with modified BFM-87 protocol Voprosy Onkologii 43(4): 414-417
Orsonneau, J.-L.; Brassart, E.A.; Lecame, M.; Thomare, P.; Delaroche, O.; Dudouet, D. 2004: Automated kinetic assay of plasmatic L-asparaginase activity undergoing therapy for acute lymphoblastic leukemia Annales de Biologie Clinique 62(5): 568-572
Ratomski, K.; Płonowski, M.; Zelazowska-Rutkowska, B.; Zak, J.; Wysocka, J.; Krawczuk-Rybak, M. 2011: Subpopulation of CD14+CD16+ monocytes in the children with acute lymphoblastic leukemia treated with filgrastim Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 30(176): 111-115
Castaman, G.; Rodeghiero, F. 1993: Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia Haematologica 78(6 Suppl 2: 57-60
Hongo, T.; Yamada, S.; Yajima, S.; Watanabe, C.; Fujii, Y.; Kawasaki, H.; Yazaki, M.; Hanada, R.; Horikoshi, Y. 1999: Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia International Journal of Hematology 70(4): 268-277
Rizzo, S.C.; Balduini, C.L.; Invernizzi, R.; Ricevuti, G.; Fontana, G.; Ascari, E. 1980: Prognostic factors and treatment response in acute lymphoblastic leukemia of children and adults treated with a non aggressive combination chemotherapy Haematologica 65(1): 70-81
Balwierz, W.; Moryl-Bujakowska, A.; Skoczeń, S.; Pawińska, K.; Balcerska, A.; Płoszyńska, A.; Chybicka, A.; Dobaczewski, G.; Juszczak, K.; Wachowiak, J.; Derwich, K.; Kowalczyk, J.; Wiśniewska-Slusarz, H.; Matysiak, Mł.; Krauze, A.; Rokicka-Milewska, R.; Pawelec, K.; Sońta-Jakimczyk, D.; Łuszczyńska, A.; Tomaszewska, R.; Wysocki, M.; Styczyński, J.; Swiatkiewicz, V. 2003: Advances in the treatment of children with high risk acute lymphoblastic leukemia (ALL) treated with modified "NEW YORK" protocols between 1987 and 2002 Przeglad lekarski 60 Suppl. 5: 13-16
Anderson, J.; Krivit, W.; Chilcote, R.; Pyesmany, A.; Chard, R.; Hammond, D. 1981: Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase IIi trial Cancer Treatment Reports 65(11-12): 1015-1019
Porkhovatyĭ, S.I. 1982: Differential diagnosis of acute lymphoblastic leukemia and the lymphoblastic variant of lymphosarcoma in children Pediatriia 11: 19-23
Armata, J.; Wyszkowski, J.; Cyklis, R.; Zajaczkowski, J.; Depowska, T. 1971: L-asparaginase in advanced acute leukemia in children Polski Tygodnik Lekarski 26(22): 826-828
Pituch, A. 1977: Peripheral blood neutrophils in children in remission of acute lymphoblastic leukaemia. Cytochemical investigations Acta Medica Polona 18(1): 69-83